NEURIM, PHARMACEUTICALS

NEURIM PHARMACEUTICALS RECIBE LA AUTORIZACIÓN EUROPEA DE COMERCIALIZACIÓN DE SLENYTO®

07.08.2025 - 18:06:29 | prnewswire.co.uk

Neurim Pharmaceuticals Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom Israel United States of America Canada Australia South Korea

View original content:https://www.prnewswire.com/news-releases/neurim-pharmaceuticals-recibe-la-autorizacion-europea-de-comercializacion-de-slenyto-302411210.html

en | boerse | 67957341 |